An Open-Label Extension Study of LUMINENZ-AT
Your child may be eligible if he/she:
• Has a
diagnosis of autism,
Your child cannot participate if he/she:
less than 48.5 pounds,
What is involved?
• Research participants will
take the autism medication for up to 180 weeks—no pills
to swallow; the
tasteless medication is sprinkled on food
What will I receive, if eligible to participate in this research study?
• A free screening assessment
• Periodic psychological testing,
• Compensation for time and travel,
• Free study medication for up to 288 weeks, and
• Regular visits with a physician and a psychologist in our clinic.
Risks and benefits will be discussed with research participants and their parent(s) prior to enrolling in the autism study.
Where does this research study take place?
We are located in the Texas Medical Center in Houston and are part of the University of Texas Health Science Center.
Who do I contact?
For further information and to find out if your child is eligible to participate in this autism clinical trial, please call Rosleen Mansour, Research Coordinator, at 713-486-2591 or email Rosleen.Mansour@uth.tmc.edu.
You may print out our flyer by clicking on the link below.
A. Pearson, Ph.D.
with comments or suggestions.